Publicaciones (27) Publicaciones en las que ha participado algún/a investigador/a

2019

  1. A nanodelivered Vorinostat derivative is a promising oral compound for the treatment of visceral leishmaniasis

    Pharmacological Research, Vol. 139, pp. 375-383

  2. A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives

    European Journal of Medicinal Chemistry, Vol. 163, pp. 569-582

  3. Alerta sanitaria por listeriosis en España. Enfoques preventivos basados en un esquema de Evaluación de Riesgos

    SEM@foro, Núm. 68, pp. 7-10

  4. Antichagasic profile of a Series of Mannich Base-Type Derivatives: Design, Synthesis, in vitro Evaluation, and Computational Studies Involving Iron Superoxide Dismutase

    ChemistrySelect, Vol. 4, Núm. 27, pp. 8112-8121

  5. Asymptomatic Leishmania infection in blood donors from the Southern of Spain

    Infection, Vol. 47, Núm. 5, pp. 739-747

  6. Bumblebees adjust protein and lipid collection rules to the presence of brood

    Current Zoology, Vol. 65, Núm. 4, pp. 437-446

  7. Comparative genomics of the major parasitic worms

    Nature Genetics, Vol. 51, Núm. 1, pp. 163-174

  8. Design, synthesis and molecular docking studies of novel N-arylsulfonyl-benzimidazoles with anti Trypanosoma cruzi activity

    European Journal of Medicinal Chemistry, Vol. 165, pp. 1-10

  9. Differential Cleaving of Specific Substrates for Cathepsin-Like Activity Shows Cysteine and Serine Protease Activities and a Differential Profile Between Anisakis simplex s.s. and Anisakis pegreffii, Sibling Species Major Etiologic Agents of Anisakiasis

    Foodborne Pathogens and Disease, Vol. 16, Núm. 11, pp. 744-751

  10. Differential proteolytic activity in Anisakis simplex s.s. and Anisakis pegreffii, two sibling species from the complex Anisakis simplex s.l., major etiological agents of anisakiasis

    Acta Tropica, Vol. 195, pp. 44-50

  11. Effective tetradentate compound complexes against leishmania spp. that act on critical enzymatic pathways of these parasites

    Molecules, Vol. 24, Núm. 1

  12. Exploiting genetically modified dual-reporter strains to monitor experimental trypanosoma cruzi infections and host-parasite interactions

    Methods in Molecular Biology (Humana Press Inc.), pp. 147-163

  13. High antiparasitic activity of silver complexes of 5,7-dimethyl-1,2,4-triazolo[1,5 a]pyrimidine

    Journal of Inorganic Biochemistry, Vol. 201

  14. In vitro assessment of 3-alkoxy-5-nitroindazole-derived ethylamines and related compounds as potential antileishmanial drugs

    Bioorganic Chemistry, Vol. 92

  15. Insights into Chagas treatment based on the potential of bacteriocin AS-48

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 10, pp. 1-8

  16. Leishmaniasis in Norway rats in Sewers, Barcelona, Spain

    Emerging Infectious Diseases

  17. Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis

    Parasites and Vectors, Vol. 12, Núm. 1

  18. New polyamine drugs as more effective antichagas agents than benznidazole in both the acute and chronic phases

    European Journal of Medicinal Chemistry, Vol. 164, pp. 27-46

  19. Phosphorylation compromises FAD binding and intracellular stability of wild-type and cancer-associated NQO1: Insights into flavo-proteome stability

    International Journal of Biological Macromolecules, Vol. 125, pp. 1275-1288

  20. Preclinical studies of toxicity and safety of the AS-48 bacteriocin

    Journal of Advanced Research, Vol. 20, pp. 129-139